Skip to main content
Fuan Pharmaceutical （Group）co.,Ltd logo

Fuan Pharmaceutical （Group）co.,Ltd — Investor Relations & Filings

Ticker · 300194 ISIN · CNE1000011G4 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,013 across all filing types
Latest filing 2021-03-30 Report Publication Anno…
Country CN China
Listing Shenzhen Stock Exchange 300194

About Fuan Pharmaceutical （Group）co.,Ltd

https://www.fapharm.com

Fuan Pharmaceutical (Group) Co., Ltd. is an integrated pharmaceutical enterprise specializing in the research, development, production, and distribution of a wide range of chemical drugs. The company operates across the entire value chain, encompassing pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and finished dosage forms. Its product portfolio primarily focuses on anti-infectives, particularly cephalosporins and penicillins, as well as treatments for cardiovascular diseases, oncology, and respiratory conditions. Fuan Pharmaceutical maintains large-scale manufacturing facilities and emphasizes technological innovation to support its diverse pipeline of generic and specialized medications. The group serves both domestic and international markets, providing essential healthcare solutions through its network of subsidiaries and specialized production bases.

Recent filings

Filing Released Lang Actions
年报披露提示性公告
Report Publication Announcement Classification · 100% confidence The document is a short announcement (293 characters) indicating that the full 2020 Annual Report will be disclosed on a specified date and website. It explicitly states that the full report is not included here but will be published later. This fits the pattern of a Report Publication Announcement (RPA) rather than the Annual Report (10-K) itself. The document does not contain financial data or detailed report content, only a notice about the report's availability.
2021-03-30 Chinese
2020年年度报告
Annual Report Classification · 100% confidence The document is titled "福安药业（集团）股份有限公司 2020 年年度报告全文" which translates to "Fuan Pharmaceutical (Group) Co., Ltd. 2020 Annual Report Full Text." It contains detailed sections typical of an annual report, including company overview, financial data for the year 2020, risk factors, business overview, management discussion and analysis, and financial statements. The document length is 15,000 characters, indicating a comprehensive report rather than a brief announcement. It includes audited financial data, management statements, and detailed business and financial analysis for the full fiscal year 2020. There is no indication that this is merely an announcement or a certification. Therefore, this document fits the definition of an Annual Report (10-K). FY 2020
2021-03-30 Chinese
关于为全资子公司使用银行授信融资提供担保的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the company providing a guarantee for a bank credit application by its wholly-owned subsidiary. It includes details about the guarantee, the subsidiary's financials, board and supervisory opinions, and compliance with stock exchange rules. There are no financial statements or comprehensive financial performance data presented, nor is this a report or transcript. The document is a formal announcement about a financing guarantee arrangement, which fits the category of Capital/Financing Update (CAP). The document length is short and focused on a specific financing guarantee event, not a full report or regulatory filing. Therefore, the appropriate classification is CAP.
2021-03-30 Chinese
关于使用闲置自有资金进行现金管理的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by the company 福安药业 regarding the use of idle self-owned funds for cash management. It details the board meeting resolution, investment overview, risk control measures, and approvals. The document is relatively short (2164 characters) and does not contain financial statements or detailed financial data. It is an announcement of a financing or capital management activity rather than a full financial report or audit. The content fits best under Capital/Financing Update (CAP) as it relates to the company's cash management and investment of idle funds.
2021-03-30 Chinese
关于拟续聘会计师事务所的公告
Audit Report / Information Classification · 95% confidence The document is an announcement regarding the proposed reappointment of an accounting firm (auditor) for the company for the upcoming fiscal year. It details the auditor's qualifications, independence, and the approval process by the board and audit committee. There are no actual financial statements or audit reports included, nor is there a detailed audit opinion or financial data. The document is relatively short (3609 characters) and serves as a formal notice about the auditor appointment to be approved at the shareholders' meeting. This fits the category of an Audit Report / Information announcement about auditor appointment rather than a full audit report or annual report. Therefore, the appropriate classification is Audit Report / Information (AR). FY 2020
2021-03-30 Chinese
关于会计政策变更的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding a change in accounting policy by the company 福安药业（集团）股份有限公司. It details the reasons for the change, the new accounting standards adopted, the impact on financial statements, and approvals by the board, independent directors, and supervisory board. The document does not contain actual financial statements or detailed financial data but is a formal disclosure of a policy change. It is not a full annual or interim report, nor an audit report. It is also not a regulatory certification or a report publication announcement. Given the nature of the content, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-03-30 Chinese

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.